Central Texas TX

Aeglea BioTherapeutics Appoints Hunter C. Smith to Board of Directors

Brenham Banner Press

Nov 16, 2021

AUSTIN, Texas, Nov. 16, 2021 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (Nasdaq: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therape…

Read the full story at Brenham Banner Press

Related places

Brenham Austin

Aeglea BioTherapeutics Appoints Hunter C. Smith to Board of Directors

Related places

More from Central Texas

CTC HVAC program sees record enrollment following instructional changes

Boil-order lifted for properties on Elms Road

Killeen workshop focuses on home ownership, financial stability and generational wealth

Two restaurant developments take shape in Harker Heights

Heikkinen Leads Hilltoppers at Old Glory Gallop

Hilltoppers Pick Up The Pace In Final Race Before Conference Meet

Bobcats Set to Close Fall Slate at Qubein Cup

Business Briefs